Home › All Companies › BNBX

BNB PLUS CORP. (BNBX)

AI-Powered SEC Filing Analysis

Quarterly Report Filed: 2026-05-15

Key Insights

  • BNB Plus Corp operates in DNA-based biotechnology with multiple revenue segments including therapeutic DNA production, DNA tagging/security products, and clinical laboratory services, indicating diversified business model exposure across healthcare and security markets.
  • The company shows recent executive compensation activity with stock option grants and warrant issuances dated October 2025 through December 2025, suggesting ongoing incentive alignment with management during the reporting period.
  • Filing structure indicates private placement capital raises occurred in October 2025 involving cash and digital assets (stablecoins), suggesting the company accessed alternative financing methods and may have cryptocurrency exposure on its balance sheet.
  • Multiple operating segments with revenue recognition at point-in-time for services including supply chain, R&D services, and large-scale DNA production suggest complex revenue recognition policies that warrant careful scrutiny of segment profitability and margins.
Sentiment: Neutral Significance: 5/10
View Original Filing →
Current Report Filed: 2026-04-29

Key Insights

  • BNB Plus Corp. received stockholder approval for a reverse stock split with a discretionary ratio between 1-for-5 and 1-for-30, granting the Board 12 months to implement the specific ratio, which typically signals efforts to restore compliance with minimum stock price requirements.
  • The reverse split proposal passed with 88.4% shareholder approval (2,420,538 votes for vs. 317,840 against), indicating strong investor support for the capital restructuring despite the dilutive nature of such actions.
  • The company's need for a reverse split suggests prior stock price deterioration and potential listing compliance concerns, which is generally a negative signal about company fundamentals and market performance.
  • The adjournment proposal also received strong approval (97.4% in favor), providing the Board flexibility to implement the reverse split at an optimal time and potentially gather additional shareholder support if needed.
Sentiment: Negative Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-31

Key Insights

  • James Haft, a director of BNB PLUS CORP. (BNBX), acquired 77,038 non-qualified stock options on 2026-03-27 with an exercise price of $0.69 and a 10-year expiration. This suggests Haft's confidence in the company's future prospects.
  • The options vest over a one-year period, with 25% vesting on the grant date and an additional 25% vesting each quarter thereafter. This vesting schedule incentivizes Haft to remain engaged with the company and work towards its long-term success.
  • As a director, Haft's acquisition of these options aligns his interests with those of other shareholders, indicating his commitment to the company's growth and performance.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-31

Key Insights

  • Joshua Kruger, the Chairman of the Board, has been granted 77,038 incentive stock options with an exercise price of $0.69 and a 10-year expiration date. This suggests the company is providing long-term equity incentives to its leadership.
  • The options vest over 4 quarters, indicating a gradual vesting schedule that aligns the Chairman's interests with long-term shareholder value creation.
  • Insider buying activity, such as this option grant, can be a positive signal for investors as it demonstrates the Chairman's confidence in the company's future prospects.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-31

Key Insights

  • Joseph D. Ceccoli, a director of BNB PLUS CORP. (BNBX), was granted 77,038 incentive stock options on March 27, 2026 with a strike price of $0.69 and a 10-year expiration date. The options vest over a 1-year period.
  • This insider stock option grant suggests that Ceccoli, a director, is bullish on the company's long-term prospects and aligns his incentives with shareholders.
  • The relatively large size of the option grant (77,038 shares) indicates that Ceccoli has a significant role and influence within the company.
Sentiment: Positive Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-03-31

Key Insights

  • Judith Murrah, a director of BNB PLUS CORP. (BNBX), acquired 77,038 incentive stock options with a strike price of $0.69 on March 27, 2026. This suggests potential insider confidence in the company's future prospects.
  • The options vest over a 4-year period, with 25% vesting on the grant date and 25% vesting per quarter thereafter. This indicates a long-term alignment between the director and the company's performance.
  • Insider transactions can provide valuable signals about a company's outlook. Investors should monitor any future Form 4 filings to track Murrah's ownership and trading activity in BNBX shares.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-31

Key Insights

  • The reporting person, Robert B. Catell, acquired 77,038 incentive stock options in BNB PLUS CORP. (BNBX) on March 27, 2026, indicating potential insider confidence in the company.
  • The options have a strike price of $0.69 and vest over a 4-year period, aligning the reporting person's interests with long-term shareholder value creation.
  • This transaction suggests the reporting person, who serves as a director of the company, is taking a bullish stance on BNBX's future prospects.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-31

Key Insights

  • The reporting person, Yacov A. Shamash, has been granted an incentive stock option to acquire 77,038 shares of BNB Plus Corp. (BNBX) common stock at an exercise price of $0.69 per share.
  • The options vest 25% on the grant date, then 25% per quarter commencing 90 days from the grant date, suggesting the company is incentivizing the reporting person to maintain a long-term stake in the company.
  • The reporting person is a director of BNB Plus Corp., indicating the option grant is likely part of the company's executive compensation program to align the interests of directors with shareholders.
Sentiment: Positive Significance: 6/10
View Original Filing →
Current Report Filed: 2026-03-24

Key Insights

  • BNB Plus Corp. has received a notification from Nasdaq that it no longer satisfies the $1.00 minimum bid price requirement for continued listing, triggering a delisting process.
  • The company plans to request a hearing before the Nasdaq Hearings Panel to appeal the delisting, which will stay any further suspension or delisting action at least pending the conclusion of the hearing process.
  • However, there is no assurance that the Panel will grant the company's request for continued listing or that the company will be able to regain compliance and maintain its Nasdaq listing.
Sentiment: Negative Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-02-13

Key Insights

  • James Haft, a director of BNB PLUS CORP. (BNBX), has disposed of 22,590 shares of the company's common stock.
  • Haft has also been granted 80,730 incentive stock options and 12,270 non-qualified stock options, all vesting over the next year.
  • The insider transactions suggest a mix of selling activity and new stock-based compensation, which could indicate changes in Haft's position or the company's incentive structure.
Sentiment: Neutral Significance: 5/10
View Original Filing →
Quarterly Report Filed: 2026-02-12

Key Insights

  • The company reported a 25% year-over-year increase in revenue for the Therapeutic DNA Production segment during Q1 2025, suggesting strong demand for its products.
  • The company's consulting arrangements with Ground Tunnel Capital LLC and Cypress Management LLC indicate strategic partnerships that could unlock new business opportunities.
  • The company raised $400,000 through an at-the-market offering in Q4 2025, which could provide additional capital to fund growth initiatives.
Sentiment: Positive Significance: 6/10
View Original Filing →
Current Report Filed: 2026-02-05

Key Insights

  • BNB Plus Corp. appointed James Haft to its Board of Directors, effective February 2, 2026, to fill a vacancy left by the resignation of Ms. Schmalz Shaheen.
  • As part of his appointment, Mr. Haft will receive a one-time cash fee of $40,000 and an initial option grant to purchase up to 93,000 shares of the company's common stock.
  • Mr. Haft has a prior $250,000 investment in the company's PIPE transaction through Gaia Digital Assets Fund, which was co-founded by his son Jacob Haft, but Mr. Haft has no involvement in the management of the fund.
Sentiment: Positive Significance: 5/10
View Original Filing →
Current Report Filed: 2026-01-22

Key Insights

  • Elizabeth M. Schmalz Shaheen has resigned from the BNB Plus Corp. board of directors, effective immediately. This leadership change could signal potential strategic shifts or changes in the company's direction.
  • The filing indicates that Ms. Schmalz Shaheen's resignation was not due to any disagreement with the company's operations, policies, or practices, suggesting it may have been for personal or professional reasons.
  • Investors should monitor any further changes in the company's board and executive team, as leadership transitions can often precede broader organizational changes that could impact the company's performance and outlook.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.